Diabetes

Metformin plus Insulin Comparable to Insulin Alone in Type 2 Diabetes

April 20, 2012

More data needed to determine whether combined use of oral therapy and insulin adds benefit

SPK Transplants May Offer No Advantage for Type 2 Diabetes

Jody A. Charnow April 17, 2012

Simultaneous pancreas-kidney (SPK) transplantation offers no patient or survival advantage over deceased-donor kidney transplantation alone (DDKA) for selected patients with type 2 diabetes, new findings suggest.

Normoalbuminuria Does Not Always Mean Normal Kidney Function

Jody A. Charnow April 16, 2012

Many patients with diabetes have significant renal dysfunction despite having normo- or microalbuminuria, according to researchers.

Bariatric Surgery Found to Reverse Diabetes

Jody A. Charnow March 26, 2012

Bariatric surgery for obese type 2 diabetics may improve and even reverse diabetes, according to the findings of two randomized, controlled studies.

Prostate Cancer Risk Higher in Diabetics

Jody A. Charnow March 09, 2012

Men with diabetes mellitus (DM) are more likely than those without the disease to have prostate cancer (PCa) found in prostate biopsy specimens, a study found.

Nut Consumers Have Lower Health Risks

Jody A. Charnow March 07, 2012

Nut consumption is associated with a decreased prevalence of certain risk factors for cardiovascular disease, type 2 diabetes, and metabolic syndrome, according to a recent study.

Renal Decline Linked to TNF Receptors

Jody A. Charnow March 01, 2012

High levels of tumor necrosis factor (TNF) receptors 1 and 2 are associated with an increased risk of kidney disease in patients with type 1 diabetes.

Highest Diabetes Death Rates Seen in Trials Selecting for CKD

February 24, 2012

Selection for chronic kidney disease associated with highest mortality rates in randomized trials

Nanoparticles May Offer New Way to Treat Type 1 Diabetes

John Schieszer February 10, 2012

Nanotechnology can deliver drugs directly to the pancreas and provide an entirely new approach to treating type 1 diabetes. Researchers have developed nanoparticles that can seek out and bind to capillary blood vessels of the islets of the pancreas.

Substances in Coffee May Prevent, Treat Diabetes

John Schieszer February 06, 2012

Compounds found in coffee may point to a new way of preventing as well as treating diabetes.

Renal Function Decline Often Precedes Macroalbuminuria in Type 2 Diabetes

Jody A. Charnow January 31, 2012

Decreases in glomerular filtration rate (GFR) frequently occur before the onset of macroalbuminuria in patients with type 2 diabetes, according to a study. A GFR decline that predicts development of end-stage renal disease (ESRD), however, strongly depends on progression to macroalbuminuria.

Diabetes May Hike Urinary Stone Risk

Jody A. Charnow January 05, 2012

Diabetes mellitus independently predicts an increased risk of urinary tract calculi (UTC), according to a population-based cohort study conducted in Taiwan.

Lab Tests Tip Off Employees to CKD, Other Conditions

Jody A. Charnow December 16, 2011

Laboratory tests performed as part of employer-sponsored health risk assessments (HRA) revealed evidence that "newly identified" at least one of three common medical conditions in more than one third of adults, a study found.

ESRD More Likely than Death for Patients with Diabetic Nephropathy

Jody A. Charnow December 07, 2011

Patients with type 2 diabetic nephropathy are more likely to progress to end-stage renal disease (ESRD) than die, according to investigators.

Shock Wave Lithotripsy Does Not Raise Diabetes Risk

Jody A. Charnow December 01, 2011

Shock wave lithotripsy is not associated with an increased risk of developing diabetes mellitus, researchers reported.

Diabetes Increases Bladder Ca Recurrence, Progression Risk

Jody A. Charnow November 21, 2011

Diabetes mellitus (DM) appears to be an independent predictor of disease recurrence and progression among patients with non-muscle invasive bladder cancer (NMIBC), according to investigators.

Renal Disease, Diabetes Linked to Uric Acid

Jody A. Charnow November 08, 2011

CHICAGO—Uncontrolled serum uric acid in patients with gout is associated with an increased risk of developing kidney disease and diabetes, according to the findings of two studies presented at the American College of Rheumatology annual meeting.

Buccal Insulin Spray for Glycemic Control

John Schieszer October 31, 2011

A buccal insulin spray may be a new treatment option for patients with impaired glucose tolerance in reducing HbA1c levels. John Schieszer has the story in today's Medical Minute.

Investigational Combo May Prevent Diabetes in Obese Patients

Jill Stein October 12, 2011

LISBON—The investigational anti-obesity compound known as controlled-release (CR) phentermine/topiramate may prevent progression to type 2 diabetes in obese patients who are prediabetic, researchers announced at the 47th annual meeting of the European Association for the Study of Diabetes.

Two-Drug Tablet for Diabetics with High Cholesterol Approved

Stephan Cho October 12, 2011

The FDA has approved Juvisync, a combination prescription medication for patients with both type 2 diabetes and high cholesterol.

Stress Management Among Latinos With Type 2 Diabetes (CALMS-D)

E-health Care Process Support for Diabetes Type II Patients (EHDI)

Mobile Diabetes Education Teams in Primary Care

Our exclusive coverage of Kidney Week 2011 in Philadelphia includes interviews, videos and noteworthy clinical reports.

Sections: Anemia | Transplantation
Secondary Hyperparathyroidism | General News
More: Videos

On The Forefront

Sickle Cell Trait and Medullary Renal Carcinoma

A 55-year-old Caucasian woman initially presented to one of Cleveland Clinic's regional outpatient urology clinics with gross hematuria and an obstructing right ureteral stone.

Your Money

In recent months, investors have been eagerly pursuing shares of Facebook, Groupon, and other hot technology companies. That has led some Wall Street analysts to worry that the stocks in the sector could be overheated and poised to sink.

Read more on
Bargain Price Stocks for Technology Companies

Expert Q&A

Optimal Sequencing of the New Prostate Cancer Drugs: An Interview with E. David Crawford, MD

Several new drugs have become available for treating advanced prostate cancer in the past year and a half. Dr. Crawford talks to Renal & Urology News about the possible ways in which these drugs might be used.